Novel peptides with orally active and long-lasting antihypertensive activity.

[1]  R. Rapaka,et al.  Polypeptide models of collagen: synthesis of (Pro-Pro-Ala)n and (Pro-Pro-Val)n. , 2009, International journal of peptide and protein research.

[2]  R. Galardy,et al.  Inhibition of angiotensin converting enzyme by phosphoramidates and polyphosphates. , 1982, Biochemistry.

[3]  R D Smith,et al.  Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at positions 2 and 5 of the hexanoic acid portion. , 1982, Journal of medicinal chemistry.

[4]  Y. Kawashima,et al.  Synthesis and Antihypertensive Activity of N-(Mercaptoacyl)-thiazolidinecarboxylic Acids , 1982 .

[5]  M. Burnier,et al.  RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers. , 1981, British journal of clinical pharmacology.

[6]  E. Lunney,et al.  Novel synthesis of (S)-1-[5-(benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogues: potent angiotensin converting enzyme inhibitors. , 1981, Journal of medicinal chemistry.

[7]  C. A. Stone,et al.  A new class of angiotensin-converting enzyme inhibitors , 1980, Nature.

[8]  R. Galardy.  Inhibition of angiotensin converting enzyme with Nα-phosphoryl-L-alanyl-L-proline and Nα-phosphoryl-L-valyl-L-tryptophan , 1980 .

[9]  H. Cheung,et al.  Design of new antihypertensive drugs: potent and specific inhibitors of angiotensin-converting enzyme. , 1978, Progress in cardiovascular diseases.

[10]  I. Mita,et al.  New sulfhydryl compounds with potent antihypertensive activities. , 1978, Chemical & pharmaceutical bulletin.

[11]  D W Cushman,et al.  Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. , 1977, Biochemistry.

[12]  B Rubin,et al.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. , 1977, Science.

[13]  E. Silverstein,et al.  A sensitive fluorimetric assay for serum angiotensin-converting enzyme. , 1976, American journal of clinical pathology.

[14]  Roba Jl.  The use of spontaneously hypertensive rats for the study of anti-hypertensive agents. , 1976 .

[15]  K. Nakata,et al.  A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446). , 1981, Japanese journal of pharmacology.

[16]  R. Soffer.  Angiotensin-converting enzyme and the regulation of vasoactive peptides. , 1976, Annual review of biochemistry.

[17]  F. R. Atherton,et al.  220. Studies on phosphorylation. Part IV. Further studies on the use of dibenzyl chlorophosphonate and the examination of certain alternative phosphorylation methods , 1948 .